1. Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA;
2. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA;
3. Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA;
4. Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, Missouri, USA;
5. Division of Gastroenterology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA;
6. Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA;
7. Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA;
8. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA;
9. Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA;
10. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA;
11. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA;
12. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany;
13. Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany;
14. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany;
15. Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia;
16. University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia;
17. Genetic Medicine and Family Cancer Clinic, The Royal Melbourne Hospital, Parkville, Victoria, Australia;
18. Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany;
19. University Medical Centre Hamburg-Eppendorf, University Cancer Centre Hamburg (UCCH), Hamburg, Germany;
20. Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada;
21. Nutrition and Metabolism Section, International Agency for Research on Cancer, World Health Organization, Lyon, France;
22. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia;
23. Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia;
24. Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia;
25. Oncology Data Analytics Program, Catalan Institute of Oncology (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain;
26. CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain;
27. Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain;
28. Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain;
29. Department of Epidemiology, University of Washington, Seattle, Washington, USA;
30. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA;
31. Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, Arizona, USA;
32. Division of Research, Kaiser Permanente Northern California, Oakland, California, USA;
33. Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA;
34. Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA;
35. Departments of Cancer Biology and Genetics and Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA;
36. Department of Radiation Sciences, Oncology Unit, Umeå University, Umeå, Sweden;
37. Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden;
38. Memorial University of Newfoundland, Discipline of Genetics, St. John's, Canada;
39. Ontario Institute for Cancer Research, Toronto, Ontario, Canada;
40. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA;
41. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA;
42. Cancer Immunology and Cancer Epidemiology Programs, Dana-Farber Harvard Cancer Center, Boston, Massachusetts, USA.